Search Results - "Liu, Moting"

The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells.

Authors: Mora, Jacob Raïch, Iu Ugalde, Valentina et al.

Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p10069. 26p.

Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis.

Authors: Xiang, Caigui Liu, Moting Lu, Qiukai et al.

Source: Cellular Immunology. Jul2021, Vol. 365, pN.PAG-N.PAG. 1p.

Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages.

Authors: Parada‐Venegas, Daniela De la Fuente López, Marjorie Dubois‐Camacho, Karen et al.

Source: FEBS Journal. Nov2025, Vol. 292 Issue 22, p6134-6157. 24p.

Identification of phosphodiesterase-4 as the therapeutic target of arctigenin in alleviating psoriatic skin inflammation.

Authors: Li, Heng Zhang, Xianglei Xiang, Caigui et al.

Source: Journal of Advanced Research. Nov2021, Vol. 33, p241-251. 11p.

Interfering with alternatively activated macrophages by CSF-1R inhibition exerts therapeutic capacity on allergic airway inflammation.

Authors: Xiang, Caigui Fan, Chen Lu, Qiukai et al.

Source: Biochemical Pharmacology. Apr2022, Vol. 198, pN.PAG-N.PAG. 1p.

Diversity-oriented synthesis of cembranoid derivatives as potential anti-inflammatory agents.

Authors: Zhang, Cong Li, Heng Liu, Jin et al.

Source: Bioorganic Chemistry. Jun2021, Vol. 111, pN.PAG-N.PAG. 1p.

Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases.

Authors: Vich Vila A Zhang J Liu M et al.

Source: Gut [Gut] 2024 Oct 07; Vol. 73 (11), pp. 1909-1920. Date of Electronic Publication: 2024 Oct 07.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis.

Authors: Liu M Zhang Y Liu J et al.

Source: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Apr 03; Vol. 30 (4), pp. 617-628.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE

Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis.

Authors: Li H Zhang Y Liu M et al.

Source: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2022 Jan; Vol. 12 (1), pp. 228-245. Date of Electronic Publication: 2021 Apr 18.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE

Discovery of Potent Antiallergic Agents Based on an o-Aminopyridinyl Alkynyl Scaffold.

Authors: Xie Z Xiang C Li X et al.

Source: Journal of medicinal chemistry [J Med Chem] 2021 Sep 23; Vol. 64 (18), pp. 13588-13603. Date of Electronic Publication: 2021 Sep 03.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE